Results for tag: "Chronic Refractory Cough Drugs"

The Chronic Refractory Cough Drugs market is a subset of the larger Respiratory Drugs market. It is composed of drugs used to treat chronic refractory cough, a condition characterized by a persistent cough that does not respond to conventional treatments. These drugs are typically used in combination with other treatments, such as lifestyle modifications, to reduce the severity of the cough. Commonly used drugs include anticholinergics, antihistamines, and mucolytics. These drugs are used to reduce inflammation, reduce mucus production, and reduce airway irritation. The Chronic Refractory Cough Drugs market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Pfizer, AstraZeneca, and Novartis. Other companies include Sanofi, Boehringer Ingelheim, and Sun Pharmaceuticals. Show Less Read more